PT  - JOURNAL ARTICLE
AU  - Yuri S. Lebedin
AU  - Olga V. Lyang
AU  - Anaida G. Galstyan
AU  - Anna V. Panteleeva
AU  - Vsevolod V. Belousov
AU  - Denis V. Rebrikov
TI  - Serum SARS-CoV-2 nucleocapsid antigen detection is essential for primary diagnostics of SARS-CoV-2-associated pneumonia
AID  - 10.1101/2020.09.24.20200303
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.24.20200303
4099  - http://medrxiv.org/content/early/2020/09/25/2020.09.24.20200303.short
4100  - http://medrxiv.org/content/early/2020/09/25/2020.09.24.20200303.full
AB  - The article highlights the diagnostic value of SARS-CoV-2 seroconversion in patients with pneumonia based on the results of a retrospective study conducted at the height of the COVID-19 pandemic in Moscow, Russia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by a grant No.075-15-2019-1789 from the Ministry of Science and Higher Education of the Russian Federation allocated to the Center for Precision Genome Editing and Genetic Technologies for BiomedicineAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was reviewed and approved by the Local Ethics Committee of the Pirogov Russian State Medical University (meeting No.194 from March 16 2020, Protocol No.2020/07); the study was conducted in accordance with the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.